Evidence map›Paper›PMID 32403297›Full record

ArticleInternational journal of environmental research and public health2020

In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters.

Jacek Piatek, Hanna Krauss, Arleta Ciechelska-Rybarczyk, Malgorzata Bernatek, Paulina Wojtyla-Buciora, Henning Sommermeyer

5 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04487834 phase2completednot on this map

Effects of Simethicone and Vivatlac Baby in Infantile Colic

TypeinterventionalSponsorThe President Stanisław Wojciechowski State University of Applied Sciences in KaliszRan2020 to 2020Enrolled87ConditionsInfantile ColicArmsSimethicone Solution, Vivatlac Baby
NCT04666324 naunknown statusnot on this map

Effects of Simethicone and Multilac Baby on Fecal Calprotectin Levels Infantile Colic

TypeinterventionalSponsorThe President Stanisław Wojciechowski State University of Applied Sciences in KaliszRan2020 to 2021Enrolled100ConditionsInfantile ColicArmsSimethicone Solution, Multilac Baby
NCT05731232 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Vivatlac Synbiotic in Patients With Irritable Bowel Syndrome - A Randomized, Double-Blind, Placebo-Controlled Clinical Trail

TypeinterventionalSponsorThe President Stanisław Wojciechowski State University of Applied Sciences in KaliszRan2023 to 2023Enrolled201ConditionsIrritable Bowel SyndromeArmsVivatlac Synbiotikum
NCT07235215 narecruitingnot on this mapstarted 2025, after this paper: background citation

Effects of Vivatlac Synbiotic in Patients With Irritable Bowel Syndrome - A Randomized, Double-blind, Placebo-Controlled, 36 Weeks Clinical Trial

TypeinterventionalSponsorThe President Stanisław Wojciechowski State University of Applied Sciences in KaliszRan2025 to 2027Enrolled200ConditionsIrritable Bowel SyndromeArmsVivatlac Synbiotic, Placebo
NCT07235228 narecruitingnot on this mapstarted 2025, after this paper: background citation

Effects of Vivatlac Synbiotic on the Gut Microbiota of Patients With Irritable Bowel Syndrome - A Randomized, Double-blind, Placebo-Controlled, 12 Weeks Clinical Trial

TypeinterventionalSponsorThe President Stanisław Wojciechowski State University of Applied Sciences in KaliszRan2025 to 2027Enrolled20ConditionsIrritable Bowel SyndromeArmsVivatlac Synbiotic, Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Inhibition ofFrontiers in microbiology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Long-Lasting Decrease of the Acquisition ofInternational journal of environmental research and public health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jacek PiatekDepartment of Medicine, The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz, Nowy Šwiat 4, 62-800 Kalisz, Poland.ORCID 0000-0003-2152-0876
Hanna KraussDepartment of Medicine, The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz, Nowy Šwiat 4, 62-800 Kalisz, Poland.
Arleta Ciechelska-RybarczykDistrict Sanitary-Epidemiological Station in Jarocin, Waska 2, 63-200 Jarocin, Poland.
Malgorzata BernatekState Hospital Jarocin, Szpitalna 1, 63-200 Jarocin, Poland.
Paulina Wojtyla-BucioraDepartment of Medicine, The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz, Nowy Šwiat 4, 62-800 Kalisz, Poland.ORCID 0000-0003-4595-1566
Henning SommermeyerDepartment of Medicine, The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz, Nowy Šwiat 4, 62-800 Kalisz, Poland.ORCID 0000-0003-1991-9327
Uniwersytet Kaliski im. Prezydenta Stanisława Wojciechowskiego · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variety of activities potentially contribute to the beneficial effects of probiotic bacteria observed in humans. Among these is a direct inhibition of the growth of pathogenic bacteria in the gut. The present study characterizes head-to-head the in-vitro pathogen growth inhibition of clinically relevant infectious bacterial strains by different types of probiotics and a synbiotic. In-vitro growth inhibition of

Indexed as

ProbioticsSynbioticsAntibiosisClostridiumEnterobacteriaceaeHumansLactobacillusOligosaccharidesPrebioticsSaccharomycesOligosaccharidesPrebioticsantimicrobial activitygut microbiomepathogen overgrowth

Identifiers

PMID32403297
PMCPMC7246756
OpenAlexW3023199094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.